LFM A13
BTK kinase inhibitor
Product Specifications
Background
LFM A13 is a potent and selective inhibitor of Bruton's tyrosine kinase (BTK).
Product Name Alternative
2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide
UNSPSC
41116105
Source
Synthetic
Purity
≥97% (TLC)
Weight
0.025
Format
Yellow solid
Solubility
Soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml)
Molecular Formula
C11H8Br2N2O2
Molecular Weight
360
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Vassilev A., Ozer Z., Navara C., Mahajan S., & Uckun F.M. (1999). J. Biol. Chem. 274(3): 1646–1656.
CAS Number
62004-35-7
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6396368-01 0.1 mL
TGFA (Protransforming Growth Factor alpha, TGF-alpha, TGFa, TGF-a, EGF-like TGF, ETGF, TGF Type 1, Transforming Growth Factor, alpha) (AP)
Ask
View Details 
MBS6396368-02 5x 0.1 mL
TGFA (Protransforming Growth Factor alpha, TGF-alpha, TGFa, TGF-a, EGF-like TGF, ETGF, TGF Type 1, Transforming Growth Factor, alpha) (AP)
Ask
View Details